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Towards a higher impact factor for the Journal of the
Chinese Medical AssociationThe Journal of the Chinese Medical Association (JCMA)
has been included in the Science Citation Index Expanded
(SCIE) since 2008. More than 8,000 scientific journals are
registered in the SCIE, and the JCMA is one of the few
journals in Taiwan to have achieved this goal.1 Now, after
serving for 9 years as the Journal’s editor-in-Chief, I am happy
to announce that it has a new impact factor of 0.678, and is
ranked at 62% (94/151) in the SCIE category “Medicine,
General and Internal”. This achievement is not only exciting
for myself, but also reflects the commitment and dedication of
our editorial team to the community of biomedical science.
Since online submission became available 3 years ago,
submissions to the Journal have continued to increase. This
trend has lowered the Journal’s acceptance rate of submitted
papers to approximately 60% this year. With this growing
influx of submissions, we are fortunate to have many experi-
enced reviewers on whom we can rely, and whose critiques
assist the Associate Editors in selecting high-quality scientific
papers. Special thanks should go to these experts, because
without their contributions the JCMAwould not have achieved
its success. On behalf of the Journal, I would like to express
my sincere appreciation to all the reviewers who have dedi-
cated their efforts to it.
An impact factor of 0.678 is not high enough in this
intensely competitive academic environment, and we should
never be satisfied; this is just the beginning of new adventures
for the JCMA. A journal’s impact factor is mainly determined
by how often papers published in it are cited within a certain
time period. Although it is widely believed that a higher
impact factor indicates a stronger scientific influence, it has
been recently reported that, in clinical medicine, the distri-
bution of citations received by articles published in journals
with a low, moderate or high impact factor is similar;2 this
suggests that articles published in journals with a low or
moderate impact factor can still be frequently cited. It is the
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doi:10.1016/j.jcma.2011.08.011on the threats from new human diseases. An example is
a paper that was published in the Journal’s February 2010
issue, during the H1N1 viral influenza pandemic.3 In this
article, which has become one of the Journal’s top-cited
papers, the authors looked at the seroprevalence rate of
H1N1 influenza virus infection among hospital staff. Another
highly cited paper reported the first case in Taiwan of infec-
tion with Klebsiella pneumoniae carrying the NDM-1 (New
Dehli metallo-b-lactamase-1) mutation, and raised concerns
about how this disease might change current clinical
practice.4
We hope to play a part in publishing important scientific
findings in all related fields of biomedical science, thus
ensuring that the JCMA will be consistently considered as an
important source of new information, and widely quoted by
researchers and scientists of different biomedical disciplines.
The strategies to accomplish this have been long in the incu-
bation period but are now about to prosper and bear fruit.
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